Trained as vascular biologist and pharmacologist, I received my PhD in Pharmaceutical Sciences from the University of Naples Federico II in Italy. During my graduate training, I unveiled the mechanisms underlying the beneficial effects of Zofenopril, a sulphydrilated angiotensin converting enzyme (ACE) inhibitor on cardiovascular functions. During my first postdoctoral training in the lab of Annarita Di Lorenzo at Weill Cornell Medicine (2013-2017), I made two major discoveries that were published in very high-impact factor journals: the endoplasmic reticulum protein Nogo-B is a crucial regulator of sphingolipid biosynthesis and sphingosine 1-phosphate (S1P) within the vascular wall (Nature Med 2015); endothelial-derived S1P and its S1P receptor-1 (S1PR1) mediated signal on endothelial cells of blood vessels is of fundamental importance in blood flow and pressure regulation (Hypertension 2017). From January 2019 I joined the lab of Ramirez Francesco at Icahn School of Medicine at Mount Sinai where I am studying the role of endothelial dysfunction in the pathogenesis of thoracic aortic aneurysm and dissection in Marfan syndrome, a connective tissue disorder caused by mutation of the extracellular matrix protein, fibrillin-1. I currently hold a position as Instructor and earned Early Career Award from the Marfan Foundation.